MK-7110
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-7110, covering 2020-01-29 to 2020-01-29. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of Efprezimod Alfa (CD24Fc, MK-7110) When Administered Intravenously in Healthy Adult Subjects (MK-7110-001) [Phase 1]